☰

Kevin J. Gaffney, Ph.D. - Publications

Affiliations: 
2013 Chemistry University of Southern California, Los Angeles, CA, United States 
Area:
synthetic organic chemistry
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Gaffney K, Weinberg M, Soto M, Louie S, Rodgers K. Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression. Haematologica. 103: e567-e570. PMID 29976741 DOI: 10.3324/Haematol.2018.193771  0.342
2015 Glynn SJ, Gaffney KJ, Sainz MA, Louie SG, Petasis NA. Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols. Organic & Biomolecular Chemistry. 13: 3887-99. PMID 25669488 DOI: 10.1039/C4Ob02512A  0.609
2014 Huang YJE, Gaffney KJ, Gerdts E, Petasis NA, Lenz H, LaBonte MJ. Abstract 1811: Evaluation of anti-CXCR2 small molecule inhibitors as novel chemotherapy targeting the Interleukin-8 pathway in colorectal cancer Cancer Research. 74: 1811-1811. DOI: 10.1158/1538-7445.Am2014-1811  0.63
2012 Thomas S, Sharma N, Golden EB, Cho H, Agarwal P, Gaffney KJ, Petasis NA, Chen TC, Hofman FM, Louie SG, Schönthal AH. Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors. Cancer Letters. 325: 63-71. PMID 22664238 DOI: 10.1016/J.Canlet.2012.05.030  0.646
2012 Jayathilaka N, Han A, Gaffney KJ, Dey R, Jarusiewicz JA, Noridomi K, Philips MA, Lei X, He J, Ye J, Gao T, Petasis NA, Chen L. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Research. 40: 5378-88. PMID 22396528 DOI: 10.1093/Nar/Gks189  0.595
2011 Ferrario A, Lim S, Xu F, Luna M, Gaffney KJ, Petasis NA, Schönthal AH, Gomer CJ. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib Cancer Letters. 304: 33-40. PMID 21339042 DOI: 10.1016/J.Canlet.2011.01.023  0.651
2010 Virrey JJ, Liu Z, Cho HY, Kardosh A, Golden EB, Louie SG, Gaffney KJ, Petasis NA, Schönthal AH, Chen TC, Hofman FM. Antiangiogenic activities of 2,5-dimethyl-celecoxib on the tumor vasculature. Molecular Cancer Therapeutics. 9: 631-41. PMID 20197398 DOI: 10.1158/1535-7163.Mct-09-0652  0.61
2010 Chen ST, Thomas S, Gaffney KJ, Louie SG, Petasis NA, Schönthal AH. Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2. Leukemia Research. 34: 250-3. PMID 19833390 DOI: 10.1016/J.Leukres.2009.09.028  0.644
2009 Cho HY, Thomas S, Golden EB, Gaffney KJ, Hofman FM, Chen TC, Louie SG, Petasis NA, Schönthal AH. Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. Cancer Letters. 282: 87-97. PMID 19345476 DOI: 10.1016/J.Canlet.2009.03.007  0.62
2009 Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Schönthal AH. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 113: 5927-37. PMID 19190249 DOI: 10.1182/Blood-2008-07-171389  0.638
2008 Chuang HC, Kardosh A, Gaffney KJ, Petasis NA, Schönthal AH. COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro Molecular Cancer. 7. PMID 18485224 DOI: 10.1186/1476-4598-7-38  0.651
Show low-probability matches.